Cargando…

Liver resection for hepatocellular carcinoma in patients with hematological malignancies

BACKGROUND: Improvements in antimetabolite drugs have prolonged the survival of patient with hematological malignancies. However, these drugs may have hepatotoxic side effects and may induce acute liver failure, chronic liver fibrosis, cirrhosis, or even hepatocellular carcinoma (HCC). Although live...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hui-Chen, Yang, Yang-Shen, Teng, Chieh-Lin Jerry, Shen, Ching-Hui, Jan, Yee-Gee, Cheng, Shao-Bin, Wu, Cheng-Chung, Lin, Yi-Ling, Huang, Chu-Chun, P’eng, Fang-Ku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667519/ https://www.ncbi.nlm.nih.gov/pubmed/29096656 http://dx.doi.org/10.1186/s12957-017-1260-y

Ejemplares similares

Liver resection for hepatocellular carcinoma in oldest old patients
por: Wu, Feng-Hsu, et al.
Publicado: (2019)

Hematopoiesis and microenvironment in hematological malignancies
por: Cheng, Hui, et al.
Publicado: (2018)

Concomitant Hepatectomy and Atrial Thrombectomy under Cardiopulmonary Bypass versus Staged Hepatectomy in the Treatment for Hepatocellular Carcinoma with Large Right Atrial Tumor Thrombi
por: Chao, Wen-Shan, et al.
Publicado: (2022)

Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies
por: Lin, Wen-Ying, et al.
Publicado: (2020)

Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies
por: Huang, Chen-Cheng, et al.
Publicado: (2021)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Splenic irradiation-induced gastric variceal bleeding in a primary splenic diffuse large B-cell lymphoma patient: a rare complication successfully treated by splenectomy with short gastric vein ligation
por: Lin, Ying-Chu, et al.
Publicado: (2012)

CAR-NK cell therapeutics for hematologic malignancies: hope is on the horizon
por: Xu, Kai-lin, et al.
Publicado: (2019)

Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor rupture
por: Lee, Chun-Yang, et al.
Publicado: (2022)

Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2019)

Efficacy and Safety of Bcl-2 Inhibitor Venetoclax in Hematological Malignancy: A Systematic Review and Meta-Analysis of Clinical Trials
por: Li, Qingfang, et al.
Publicado: (2019)

A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

Outcomes and Prognostic Factors in Critical Patients with Hematologic Malignancies
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

Nontyphoidal Salmonella Infection Associated with Subsequent Risk of Hematological Malignancies: A Nationwide Population-Based Cohort Study
por: Yun, Chih-Hui, et al.
Publicado: (2022)

The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities
por: Que, Jenny Y, et al.
Publicado: (2014)

Association between palliative care and end-of-Life care for patients with hematological malignancies: A population-based study
por: Chiang, Jui-Kun, et al.
Publicado: (2019)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

The potential of using itaconate as treatment for inflammation-related heart diseases
por: Ku, Hui-Chen, et al.
Publicado: (2021)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
por: Tsai, Chia-Jung, et al.
Publicado: (2023)

Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma
por: Que, Jenny, et al.
Publicado: (2016)

Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies
por: Liao, Chun-Ta, et al.
Publicado: (2015)

Intestinal Microbes and Hematological Malignancies
por: Zhu, Yinghong, et al.
Publicado: (2023)

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
por: Zhang, Xiaomin, et al.
Publicado: (2022)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

Molecular-Targeted Therapies for Hematologic Malignancies
por: Bunting, Kevin D., et al.
Publicado: (2012)

Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks
por: Yang, Pinghua, et al.
Publicado: (2023)

Hepatic resection for hepatocellular carcinoma in the octogenarian: is it justified?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Characteristics of pathogens detected in adults with hematological malignancies and nosocomial infections in the tropics
por: Dou, Li-Ping, et al.
Publicado: (2020)

Diffuse bone marrow metastasis of cancer cells mimicking hematologic malignancy in a case of rhabdomyosarcoma
por: Wei, Chao‐Hung, et al.
Publicado: (2020)

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
por: Zhao, Ailin, et al.
Publicado: (2023)

Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023)

Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2011)

Malignant choroidal melanoma with suspected vitreous seeding - A case report
por: Cheng, Wen-Hsin, et al.
Publicado: (2017)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Epigenetic inactivation of the MIR129-2 in hematological malignancies
por: Wong, Kwan-Yeung, et al.
Publicado: (2013)

Mitochondrial transfer in hematological malignancies
por: Guo, Xiaodong, et al.
Publicado: (2023)

Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway
por: Ku, Chung-Yu, et al.
Publicado: (2015)

Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma
por: Ku, Chung-Yu, et al.
Publicado: (2016)

ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis
por: Wang, Yen-Ching, et al.
Publicado: (2021)

Association between IPTA Gene Polymorphisms and Hematological Abnormalities in Hepatitis C Virus-Infected Patients Receiving Combination Therapy
por: Hwang, Jow-Jyh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_evcmjskq0d06n0eo3iinq2qat8